Organonitrogen Compounds
Medchemexpress LLC (R)-Amlodipine | 103129-81-3 | 99.5% | 5 MG
(R)-Amlodipine is the R-enantiomer of Amlodipine. This compound is intended for research use only and is not suitable for patient use.
- High purity: 99.45%
- Documentation available: data sheet, COA, SDS, handling instructions, HNMR, LCMS
- Detailed solubility information provided for in vitro and in vivo dissolution
- Related research tools, antibodies, and screening libraries are available
- Classified under membrane transporter/ion channel, neuronal signaling, and calcium channel
- Related to disease areas such as blood or cardio-cerebrovascular disease, cancer, and cardiovascular disease
Medchemexpress LLC Amlodipine | 88150-42-9 | 99.87% | 5 G
Amlodipine is an antianginal agent and an orally active dihydropyridine calcium channel blocker. It functions by blocking voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. It can be used in the research of high blood pressure and cancer.
- Functions as an antianginal agent
- Orally active dihydropyridine calcium channel blocker
- Blocks voltage-dependent L-type calcium channels
- Inhibits initial influx of calcium
- Suitable for research on high blood pressure
- Suitable for research on cancer
Sigma Aldrich Fine Chemicals Biosciences Amlodipine besylate >=98% (HPLC) | 111470-99-6 | MFCD00887594 | 50MG
Amlodipine besylate >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 567.05 | 111470-99-6 | MFCD00887594 | 50MG
Apexbio Technology LLC Mesoridazine Besylate 32672-69-8 10mM (in 1mL DMSO)
Mesoridazine besylate (CAS 32672-69-8) is a phenothiazine derivative that functions primarily as a dopamine receptor antagonist demonstrating notable inhibitory activity against dopamine D2 and D4 receptors The molecule has particularly high affinity toward the dopamine D4 receptor subtype By modulating dopamine receptor activity Mesoridazine besylate has potential relevance in neuroscience research aimed at understanding dopamine-mediated neurological pathways and disorders Frequently utilized in studies of psychotic conditions the compound serves as an important tool for investigating receptor-specific pharmacological mechanisms
eMolecules 863548-47-4 | 3-(Aminomethyl)-N,N-dimethylbenzamide | Combi-Blocks | MFCD07186284 | 178.235 | C10H14N2O | 95.000 | CN(C)C(=O)c1cccc(CN)c1 | 1g | 117567135
3-(Aminomethyl)-N,N-dimethylbenzamide | Combi-Blocks | 863548-47-4 | MFCD07186284 | 178.235 | C10H14N2O | 95.000 | CN(C)C(=O)c1cccc(CN)c1 | 1g | 117567135
Medchemexpress LLC NCC-149 | 1316652-41-1 | 98.7% | 326.37 g/mol | C16H14N4O2S | 1 ML
NCC-149 is a selective HDAC8 inhibitor intended for in vitro research applications, including neural differentiation studies. It is supplied as either a 10 mM solution in DMSO or as a solid for reconstitution, and is characterized by reported high purity and a defined molecular weight.
- Selective HDAC8 inhibition suitable for mechanistic and cellular studies.
- Useful for neural differentiation research and related assays.
- Available as 10 mM solution in DMSO or as solid for preparation of stock solutions.
- High reported purity supports reproducible experimental results.
- Defined molecular weight and formula simplify calculation of working concentrations.
Medchemexpress LLC Methyl but-3-enoate 100g
Methyl but-3-enoate is a drug intermediate for synthesis of various active compounds